In this EducateNext, Ms. LaDuca will present detailed results from a recent study exploring racial and ethnic differences in cancer genetic testing results for women with breast cancer. Results from this study and others will be used to highlight opportunities to improve the utility of genetic testing in populations facing health inequalities.
Race, Ethnicity, and Clinical Utility in Cancer Genetics with Holly LaDuca, MS, CGC
Associate Director, Clinical Research, Ambry Genetics
Ms. LaDuca is a board-certified genetic counselor. In her current role as Associate Director of Clinical Research at Ambry Genetics, Ms. LaDuca oversees clinical research efforts, focusing on the translational application of Ambry’s research. Her research interests include clinical implementation of polygenic risk scores and improving access to risk assessment and genetic testing. Ms. LaDuca received her M.S. in Genetic Counseling from Northwestern University and practiced clinically as a cancer genetic counselor prior to joining Ambry eight years ago.
Genomic Science Liaison, Ambry Genetics
Lindsay Lipe is an Oncology Genomic Science Liaison at Ambry Genetics for the Bluegrass Region. She completed her Bachelor of Science in Zoology at Michigan State University and her Master of Science in Genetic Counseling at Wayne State University. She worked as a clinical genetic counselor at the West Cancer Center in Memphis, TN prior to starting at Ambry. In her current role, she serves as a clinical liaison for the field team to educate health care providers and key opinion leaders on genetic testing and genomic medicine. Lindsay is a member of the National Society of Genetic Counselors (NSGC) and is licensed as a genetic counselor by the TN Department of Health. She is board-certified by the American Board of Genetic Counseling (ABGC).
- Fri, November 13, 2020
- 10:00am PST
- Duration: 1 hour
-
C.E.U.
1 Category 1 Contact Hour
- P.A.C.E. 1 unit